Literature DB >> 33322508

Primary Central Nervous System Lymphomas: A Diagnostic Overview of Key Histomorphologic, Immunophenotypic, and Genetic Features.

Marietya I S Lauw1, Calixto-Hope G Lucas1, Robert S Ohgami1,2, Kwun Wah Wen1,2.   

Abstract

Primary central nervous system lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin lymphoma that primarily arises in the brain, spinal cord, leptomeninges, and vitreoretinal compartment of the eye. The term is sometimes used interchangeably with primary central nervous system diffuse large B-cell lymphoma (PCNS DLBCL) because DLBCL comprises a great majority (90-95%) of PCNSL. Although rare, other types of lymphomas can be seen in the central nervous system (CNS), and familiarity with these entities will help their recognition and further workup in order to establish the diagnosis. The latter is especially important in the case of PCNSL where procurement of diagnostic specimen is often challenging and yields scant tissue. In this review, we will discuss the most common types of primary lymphomas that can be seen in the CNS with emphasis on the diagnostic histomorphologic, immunophenotypic, and molecular genetic features. The differential diagnostic approach to these cases and potential pitfalls will also be discussed.

Entities:  

Keywords:  Burkitt lymphoma; anaplastic large cell lymphoma (ALCL); dural marginal zone lymphoma (MZL) of mucosa-associated lymphoid tissue (MALT lymphoma); intravascular large B-cell lymphoma; peripheral T-cell lymphoma, NOS (PTCL, NOS); primary central nervous system diffuse large B-cell lymphoma (PCNS DLBCL); primary central nervous system lymphoma (PCNSL)

Year:  2020        PMID: 33322508      PMCID: PMC7764608          DOI: 10.3390/diagnostics10121076

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  82 in total

1.  Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma.

Authors:  Manuel Montesinos-Rongen; Elzbieta Godlewska; Anna Brunn; Otmar D Wiestler; Reiner Siebert; Martina Deckert
Journal:  Acta Neuropathol       Date:  2011-10-22       Impact factor: 17.088

Review 2.  Rare case of a primary non-dural central nervous system low grade B-cell lymphoma and literature review.

Authors:  Antonios Papanicolau-Sengos; Jessica Wang-Rodriguez; Huan-You Wang; Roland R Lee; Anna Wong; Lawrence A Hansen; Sepi Mahooti; Hooman H Rashidi
Journal:  Int J Clin Exp Pathol       Date:  2012-01-01

3.  Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment.

Authors:  M Montesinos-Rongen; R Küppers; D Schlüter; T Spieker; D Van Roost; C Schaller; G Reifenberger; O D Wiestler; M Deckert-Schlüter
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

4.  Gene expression and angiotropism in primary CNS lymphoma.

Authors:  James L Rubenstein; Jane Fridlyand; Arthur Shen; Ken Aldape; David Ginzinger; Tracy Batchelor; Patrick Treseler; Mitchel Berger; Michael McDermott; Michael Prados; Jon Karch; Craig Okada; William Hyun; Seema Parikh; Chris Haqq; Marc Shuman
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

5.  Clinicopathological features of primary diffuse large B-cell lymphoma of the central nervous system - strong EZH2 expression implying diagnostic and therapeutic implication.

Authors:  Shuangping Guo; Qingxian Bai; Joseph Rohr; Yingmei Wang; Yang Liu; Kaixuan Zeng; Kangjie Yu; Xiumin Zhang; Zhe Wang
Journal:  APMIS       Date:  2016-11-02       Impact factor: 3.205

6.  BCL2 expression is associated with a poor prognosis independent of cellular origin in primary central nervous system diffuse large B-cell lymphoma.

Authors:  Keishi Makino; Hideo Nakamura; Naoki Shinojima; Jun-Ichiro Kuroda; Shigetoshi Yano; Yoshiki Mikami; Akitake Mukasa
Journal:  J Neurooncol       Date:  2018-07-02       Impact factor: 4.130

7.  High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.

Authors:  Anne M R Schrader; Patty M Jansen; Rein Willemze; Maarten H Vermeer; Anne-Marie Cleton-Jansen; Sebastiaan F Somers; Hendrik Veelken; Ronald van Eijk; Willem Kraan; Marie José Kersten; Michiel van den Brand; Wendy B C Stevens; Daphne de Jong; Myrurgia Abdul Hamid; Bea C Tanis; Eduardus F M Posthuma; Marcel Nijland; Arjan Diepstra; Steven T Pals; Arjen H G Cleven; Joost S P Vermaat
Journal:  Blood       Date:  2018-03-07       Impact factor: 22.113

8.  Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases.

Authors:  Eyas M Hattab; Sarah E Martin; Sohaib M Al-Khatib; William J Kupsky; Gail H Vance; Ryan A Stohler; Magdalena Czader; Mousa A Al-Abbadi
Journal:  Mod Pathol       Date:  2009-11-20       Impact factor: 7.842

9.  Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma.

Authors:  H Schwindt; I Vater; M Kreuz; M Montesinos-Rongen; A Brunn; J Richter; S Gesk; O Ammerpohl; O D Wiestler; D Hasenclever; M Deckert; R Siebert
Journal:  Leukemia       Date:  2009-06-04       Impact factor: 11.528

10.  Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas.

Authors:  Anna Brunn; Inga Nagel; Manuel Montesinos-Rongen; Wolfram Klapper; Inga Vater; Werner Paulus; Volkmar Hans; Ingmar Blümcke; Joachim Weis; Reiner Siebert; Martina Deckert
Journal:  Acta Neuropathol       Date:  2013-09-06       Impact factor: 17.088

View more
  6 in total

Review 1.  Point Mutation Specific Antibodies in B-Cell and T-Cell Lymphomas and Leukemias: Targeting IDH2, KRAS, BRAF and Other Biomarkers RHOA, IRF8, MYD88, ID3, NRAS, SF3B1 and EZH2.

Authors:  Kunwar Singh; Sumanth Gollapudi; Sasha Mittal; Corinn Small; Jyoti Kumar; Robert S Ohgami
Journal:  Diagnostics (Basel)       Date:  2021-03-27

2.  Clinical Outcomes of RTOG 9310 Protocol for Primary Central Nervous System Lymphoma: Single-Center Experience with 87 Patients.

Authors:  Jinuk Kim; Tae Gyu Kim; Hyoun Wook Lee; Seok Hyun Kim; Ji Eun Park; Moonok Lee; Young Zoon Kim
Journal:  Curr Oncol       Date:  2021-11-12       Impact factor: 3.677

3.  First observation of intraocular extranodal natural killer/T-cell lymphoma secondary to a retroperitoneal tumour: a case report and comparative review.

Authors:  Binyao Chen; Shizhao Yang; Wenru Su
Journal:  BMC Ophthalmol       Date:  2022-03-26       Impact factor: 2.209

Review 4.  Clinical Presentation and MRI Characteristics of Appendicular Soft Tissue Lymphoma: A Systematic Review.

Authors:  Sebastian Weiss; Valentin Weisse; Alexander Korthaus; Peter Bannas; Karl-Heinz Frosch; Carsten Schlickewei; Alexej Barg; Matthias Priemel
Journal:  Diagnostics (Basel)       Date:  2022-07-04

5.  Intraparenchymal Mucosa-Associated Lymphoid Tissue Lymphoma: A Case Report.

Authors:  Pedram Laghaei Farimani; Vishwathsen Karthikeyan; Mostafa Fatehi; Adrian Levine; Graham W Slack; Ian R Mackenzie; Charles Haw
Journal:  Cureus       Date:  2022-08-23

Review 6.  Extranodal classical Hodgkin lymphoma involving the spinal cord: case report and review of the literature.

Authors:  Katell Le Dû; Nicolas Alarion; Hassan Rabi; Olivier Casasnovas; Philippine Robert; Amandine Durand; Bénédicte Burlet; Claire Tabouret-Viaud; Selim Ramla; Laurent Martin; Cédric Rossi
Journal:  CNS Oncol       Date:  2022-06-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.